Rafael Holdings, Inc. Class B Common Stock

RFLNYSE • USD
0.95 USD
↘ 0.02 (2.48%)🟢LIVE (AS OF 02:24 PM EST)
🟢Market: OPEN

Rafael Holdings, Inc. Class B Common Stock (RFL) is currently trading at $0.95. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place RFL at a fair price relative to peers.

Technical & fundamental data as of Nov 16, 2026.

Open?$1.00
High?$1.00
Low?$0.87
Prev. Close?$0.97
Volume?74.3K
Avg. Volume?66.5K
VWAP?$0.95
Rel. Volume?1.12x
Bid / Ask
Bid?$0.90 × 500
Ask?$0.99 × 100
Spread?$0.10
Midpoint?$0.94
Valuation & Ratios
Market Cap?50.6M
Shares Out?51.4M
Float?34.2M
Float %?66.8%
P/E Ratio?N/A
P/B Ratio?0.76
EPS?-$0.57
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
Employees
17
Market Cap
50.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-03-06
Address
520 BROAD STREET
NEWARK, NJ 07120
Phone: 212-658-1450
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
40
Short Sent.?
88
Piotroski F-Score?3/9Weak
Altman Z-Score?-2.78Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?0.86%Low
Short Interest?292.9K
Days to Cover?5.2
Free Float34.2M
Avg Daily Volume56.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?2.35Strong
Quick Ratio?2.32Strong
Cash Ratio?2.01Strong
Debt/Equity?0.01Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.76CHEAP▾
P/S?
Peers
100
S&P
3
57.92HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.9CHEAP▾
EV/Sales?
Peers
100
S&P
3
33.36HIGH▾
Returns & Efficiency
ROE?
S&P
3
-44.7%WEAK▾
ROA?
S&P
3
-35.7%WEAK▾
Cash Flow & Enterprise
FCF?$-29990000
Enterprise Value?$29.2M
Fundamentals ratios updated end of day